Information Provided By:
Fly News Breaks for April 26, 2016
TROV
Apr 26, 2016 | 05:54 EDT
Leerink analyst Dan Leonard downgraded Trovagene to Market Perform saying the senior leadership transitions "could prove disruptive." The analyst cut his price target for the shares to $4.50 from $8.
News For TROV From the Last 2 Days
There are no results for your query TROV